← All Sponsors
SPONSOR

Hackensack Meridian Health

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Prostate Adenocarcinoma
NCT06798558 Phase 2
Recruiting

Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

Prostate Adenocarcinoma
United States View Trial →